Contents

Current Cancer Drug Targets, Volume 8 - Number 2

Editorial [ Apoptotic Pathways as Targets for Therapeutic Intervention Guest Editor: Domagoj Vucic ]

, 8(2): 86

Domagoj Vucic


DOI: 10.2174/156800908783769364




p53: A Guide to Apoptosis

, 8(2): 87 - 97

Erik Meulmeester and Aart G. Jochemsen


DOI: 10.2174/156800908783769337




Targeting Cell Death in Tumors by Activating Caspases

, 8(2): 98 - 109

A. Clay Clark and Sarah H. MacKenzie


DOI: 10.2174/156800908783769391




Targeting IAP (Inhibitor of Apoptosis) Proteins for Therapeutic Intervention in Tumors

, 8(2): 110 - 117

Domagoj Vucic


DOI: 10.2174/156800908783769373




Ubiquitylation and Cancer Development

, 8(2): 118 - 123

John Silke, Maria Miasari and Hamsa Puthalakath


DOI: 10.2174/156800908783769300




Tumor Necrosis Factor: Renaissance as a Cancer Therapeutic?

, 8(2): 124 - 131

D. Daniel and N. S. Wilson


DOI: 10.2174/156800908783769346




Modulation of TRAIL-Induced Apoptosis by HDAC Inhibitors

, 8(2): 132 - 140

Simone Fulda


DOI: 10.2174/156800908783769355




Application of Proteome Analysis to the Assessment of Prognosis and Response Prediction in Clinical Oncology

, 8(2): 141 - 145

Christoph Rocken, Ralf Ketterlinus and Matthias P.A. Ebert


DOI: 10.2174/156800908783769328




Natural and Synthetic Agents Targeting Inflammation and Angiogenesis for Chemoprevention of Prostate Cancer

, 8(2): 146 - 155

Spiridione Garbisa, Elena M.V. Araldi, Isabella Dell'Aica, Ilaria Sogno, Girieca Lorusso and Adriana Albini


DOI: 10.2174/156800908783769382




Novel Monoclonal Antibodies for the Treatment of Chronic Lymphocytic Leukemia

, 8(2): 156 - 171

Tadeusz Robak


DOI: 10.2174/156800908783769319




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science